Inventor · disambiguated record
Charles H. Reynolds
Also filed as: REYNOLDS CHARLES · REYNOLDS CHARLES H · REYNOLDS CHARLES HOWARD
28 granted patents·4 pending applications·137 citations·filing 1993–2025
96Inventor score
Files withSHY Therapeutics LLC17JANSSEN PHARMACEUTICA NV4ROHM & HAAS3BAXTER ELLEN2MADRIGAL PHARMACEUTICALS INC2
Top patents by PatentIndex Score
32 records- 0196US11629136B1Substituted pyridine derivatives as SARM1 inhibitorsNURA BIO INC·Filed 2022·Granted Apr 18, 2023·4 cites·29 claims
- 0295US10376517B2Methods of synthesizing thyroid hormone analogs and polymorphs thereofMADRIGAL PHARMACEUTICALS INC·Filed 2018·Granted Aug 13, 2019·9 cites·25 claims
- 0394US9968612B2Method of synthesizing thyroid hormone analogs and polymorphs thereofMADRIGAL PHARMACEUTICALS INC·Filed 2016·Granted May 15, 2018·9 cites·18 claims
- 0493US12168668B2Compounds for the treatment of cancer and inflammatory diseaseSHY Therapeutics LLC·Filed 2022·Granted Dec 17, 2024·1 cites·16 claims
- 0592US12110285B2Substituted pyridine derivatives as SARM1 inhibitorsNURA BIO INC·Filed 2023·Granted Oct 8, 2024·1 cites·19 claims
- 0692US10870657B2Compounds for the treatment of cancer and inflammatory diseaseSHY Therapeutics LLC·Filed 2019·Granted Dec 22, 2020·4 cites·7 claims
- 0790US11026930B1Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic diseaseSHY Therapeutics LLC·Filed 2020·Granted Jun 8, 2021·2 cites·16 claims
- 0888US10588894B2Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic diseaseSHY Therapeutics LLC·Filed 2018·Granted Mar 17, 2020·4 cites·6 claims
- 0988US10221191B2Compounds for the treatment of cancer and inflammatory diseaseSHY Therapeutics LLC·Filed 2016·Granted Mar 5, 2019·5 cites·5 claims
- 1087US2025122216A1Compounds for the Treatment of Cancer and Inflammatory DiseaseSHY Therapeutics LLC·Filed 2024·Application pending·0 cites
- 1186US10940139B2Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic diseaseSHY Therapeutics LLC·Filed 2019·Granted Mar 9, 2021·3 cites·27 claims
- 1286US7531545B22-amino-3,4-dihydro-pyrido[3,4-d]pyrimidine derivatives useful as inhibitors of β-secretase (BACE)JANSSEN PHARMACEUTICA NV·Filed 2006·Granted May 12, 2009·14 cites·14 claims
- 1385US11000515B2Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic diseaseSHY Therapeutics LLC·Filed 2019·Granted May 11, 2021·2 cites·58 claims
- 1484US10933054B2Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic diseaseSHY Therapeutics LLC·Filed 2019·Granted Mar 2, 2021·2 cites·30 claims
- 1583US6270748B1Contrast enhancing agent having a polymeric core and polymeric shellROHM & HAAS·Filed 2000·Granted Aug 7, 2001·52 cites·10 claims
- 1681US2023149369A1Compounds that Interact with the Ras Superfamily for the Treatment of Cancers, Inflammatory Diseases, Rasopathies, and Fibrotic DiseaseSHY Therapeutics LLC·Filed 2022·Application pending·0 cites
- 1778US12391705B2Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic diseaseSHY Therapeutics LLC·Filed 2019·Granted Aug 19, 2025·1 cites·27 claims
- 1878US11541041B1Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, Rasopathies, and fibrotic diseaseSHY Therapeutics LLC·Filed 2021·Granted Jan 3, 2023·0 cites·39 claims
- 1978US7868022B22-amino-quinoline derivatives useful as inhibitors of β-secretase (BACE)JANSSEN PHARMACEUTICA NV·Filed 2007·Granted Jan 11, 2011·5 cites·15 claims
- 2076US11213515B1Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic diseaseSHY Therapeutics LLC·Filed 2021·Granted Jan 4, 2022·0 cites·33 claims
- 2174US7932261B2Macrocycle derivatives useful as inhibitors of β-secretase (BACE)JANSSEN PHARMACEUTICA NV·Filed 2007·Granted Apr 26, 2011·2 cites·8 claims
- 2273US11560390B2Compounds for the treatment of cancer and inflammatory diseaseSHY Therapeutics LLC·Filed 2020·Granted Jan 24, 2023·0 cites·5 claims
- 2373US7786116B22-amino-quinoline derivatives useful as inhibitors of β-secretase (BACE)JANSSEN PHARMACEUTICA NV·Filed 2009·Granted Aug 31, 2010·2 cites·11 claims
- 2472US5397793AHeterocyclicacetonitriles and fungicidal useROHM & HAAS·Filed 1993·Granted Mar 14, 1995·12 cites·12 claims
- 2571US12459951B2Compounds that interact with RAS superfamily proteins for treatment of cancers, inflammatory diseases, rasopathies, and fibrotic diseaseSHY Therapeutics LLC·Filed 2024·Granted Nov 4, 2025·0 cites·46 claims
- 2669US2025296938A1Compounds that Interact with the Ras Superfamily for the Treatment of Cancers, Inflammatory Diseases, Rasopathies, and Fibrotic DiseaseSHY Therapeutics LLC·Filed 2025·Application pending·0 cites
- 2766US8426429B22-amino-quinazoline derivatives useful as inhibitors of β-secretase (BACE)BAXTER ELLEN·Filed 2005·Granted Apr 23, 2013·1 cites·13 claims
- 2864US2025289825A1Compounds that interact with ras superfamily proteins for treatment of cancers, inflammatory diseases, rasopathies, and fibrotic diseaseSHY Therapeutics LLC·Filed 2025·Application pending·0 cites
- 2946US5484787AHeterocyclicacetonitriles and fungicidal useROHM & HAAS·Filed 1994·Granted Jan 16, 1996·2 cites·12 claims
- 3045US8076358B26-substituted-thio-2-amino-quinoline derivatives useful as inhibitors of β-secretase (BACE)BAXTER ELLEN·Filed 2009·Granted Dec 13, 2011·0 cites·13 claims
- 3136US8383637B22-amino-quinazoline derivatives useful as inhibitors of β-secretase (BACE)JANSSSEN PHARMACEUTICA N V·Filed 2005·Granted Feb 26, 2013·0 cites·13 claims
- 3235US11649237B2Substituted imidazo[1,5-a]pyrazines for IRE1 inhibitionOPTIKIRA LLC·Filed 2018·Granted May 16, 2023·0 cites·18 claims
Join the waitlist — get patent alerts
Get an alert when Charles H. Reynolds files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →